Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arteaga

Showing results (11-20 of 4,009) with videos related to

Pageof 401
Sort By:
Revista Medica De Chile|April 1, 1976
[Water, electrolyte and acid-base disturbances in uncontrolled diabetes mellitus (author's transl)]A Arteaga
Molecules (Basel, Switzerland)|February 8, 2012
Communic acids: occurrence, properties and use as chirons for the synthesis of bioactive compoundsAlejandro F Barrero, M Mar Herrador, Pilar Arteaga, et al.
Chemical Communications (Cambridge, England)|June 8, 2017
Multifunctional catalysis: stereoselective construction of α-methylidene-γ-lactams via an amidation/Rauhut-Currier sequenceKenta Kishi, Fernando Arteaga Arteaga, Shinobu Takizawa, et al.
Asclepio; Archivo Iberoamericano De Historia De La Medicina Y Antropologia Medica|December 31, 2010
[Physical anthropology and human "zoos": the exhibition of natives as a scientific popularization practice on the threshold of the 20th century]Juanma Sánchez Arteaga
Current Topics in Microbiology and Immunology|July 2, 2010
Clinical development of phosphatidylinositol-3 kinase pathway inhibitorsCarlos L Arteaga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2006
Can trastuzumab be effective against tumors with low HER2/Neu (ErbB2) receptors?Carlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Cdk inhibitor p27Kip1 and hormone dependence in breast cancerCarlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2011
Why is this effective HSP90 inhibitor not being developed in HER2+ breast cancer?Carlos L Arteaga
Journal. American Public Health Association|July 15, 2009
Section of Municipal Health Officers: DIPHTHERIA AND ITS PROPHYLAXISJ F Arteaga
Current Opinion in Genetics & Development|December 27, 2005
Inhibition of TGFbeta signaling in cancer therapyCarlos L Arteaga
Pageof 401

Showing results (11-20 of 4,009) with videos related to

Sort By:
Pageof 401
Revista Medica De Chile|April 1, 1976
[Water, electrolyte and acid-base disturbances in uncontrolled diabetes mellitus (author's transl)]A Arteaga
Molecules (Basel, Switzerland)|February 8, 2012
Communic acids: occurrence, properties and use as chirons for the synthesis of bioactive compoundsAlejandro F Barrero, M Mar Herrador, Pilar Arteaga, et al.
Chemical Communications (Cambridge, England)|June 8, 2017
Multifunctional catalysis: stereoselective construction of α-methylidene-γ-lactams via an amidation/Rauhut-Currier sequenceKenta Kishi, Fernando Arteaga Arteaga, Shinobu Takizawa, et al.
Asclepio; Archivo Iberoamericano De Historia De La Medicina Y Antropologia Medica|December 31, 2010
[Physical anthropology and human "zoos": the exhibition of natives as a scientific popularization practice on the threshold of the 20th century]Juanma Sánchez Arteaga
Current Topics in Microbiology and Immunology|July 2, 2010
Clinical development of phosphatidylinositol-3 kinase pathway inhibitorsCarlos L Arteaga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2006
Can trastuzumab be effective against tumors with low HER2/Neu (ErbB2) receptors?Carlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Cdk inhibitor p27Kip1 and hormone dependence in breast cancerCarlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2011
Why is this effective HSP90 inhibitor not being developed in HER2+ breast cancer?Carlos L Arteaga
Journal. American Public Health Association|July 15, 2009
Section of Municipal Health Officers: DIPHTHERIA AND ITS PROPHYLAXISJ F Arteaga
Current Opinion in Genetics & Development|December 27, 2005
Inhibition of TGFbeta signaling in cancer therapyCarlos L Arteaga
Pageof 401